KVWL
Administrative building of the KVWL in Dortmund
A series of lawsuits now before Frankfurt Regional Court is shedding new light on one of Germany's more unusual real estate investment failures. Research by NDR, WDR and the Süddeutsche Zeitung has established that at least 17 statutory health insurance funds and associations of panel doctors (KVen) invested in financial products linked to the Verius property funds, incurring confirmed losses exceeding €170 million. Sources within the financial firms involved suggest total investments may have exceeded €500 million, although not all institutions have disclosed the extent of their exposure.
To understand how those losses occurred, it helps to understand what Verius actually did.
Verius Capital is a Swiss-based investment manager specialising in real estate financing rather than direct property ownership. Its funds raised capital from institutional investors before advancing it to German and Austrian property developers, largely through subordinated or mezzanine loans used to finance development projects. The model depended upon buoyant property markets and readily available refinancing. Once interest rates rose sharply and refinancing conditions deteriorated, many of those loans came under severe pressure.
Yet the health insurers and KVen did not invest directly in Verius' lending funds. According to the investigations, they acquired securities issued through a Luxembourg special-purpose vehicle whose cash flows ultimately depended on subordinated loans made by Verius. On paper, they held what appeared to be a conventional fixed-income investment. In reality, they were exposed to mezzanine development finance, one of the highest-risk segments of the real estate market.
When conservative investment rules meet complex products
The most striking individual case is the KV Baden-Württemberg, the association responsible for distributing health insurance payments to panel doctors across south-west Germany. Between 2019 and 2022 it invested €50 million through the Verius structure. According to its statement of claim, that investment has effectively "vanished into thin air", with 96.3% of the capital allegedly lost.
The KV Schleswig-Holstein, which invested €16 million, now regards its investment as a total loss, while KV Hessen has confirmed investments of €30 million. Among the health insurers, KKH invested €47.4 million, Pronova BKK €10 million and BKK Gildemeister Seidensticker €7.9 million. A further five insurers — AOK Bremen, Bahn BKK, BKK Pfalz, Siemens BKK and Viactiv — have acknowledged investments but declined to disclose the sums involved.
The significance of the affair lies partly in the rules governing these institutions. Book IV of Germany's Social Code requires statutory health insurance funds and KVen to invest their operating funds, reserves and administrative assets conservatively, in a way that "a loss appears to be ruled out". They are custodians of public money, not return-seeking institutional investors.
Against that background, the attraction of the Verius investments becomes clearer. The products reportedly offered returns of more than 7% during a prolonged period of ultra-low interest rates. For Stefan Loipfinger, the independent analyst who has long examined weaknesses in Germany's property fund sector, that alone should have raised questions. If a product promised returns above 7% when interest rates were close to zero, he argues, investors should have recognised that those returns reflected correspondingly higher risks. In his view, the Verius products were "definitely unsuitable" for institutions whose statutory duty was to preserve capital.
The litigation widens
The lawsuits now before Frankfurt Regional Court, coordinated by law firm Hogan Lovells and drafted in largely identical terms, allege that investors were repeatedly assured during meetings and conference calls that the investments were conservative and complied with the requirements of the Social Code. The claims further contend that the investment documentation created the impression of a safe, low-risk investment while failing adequately to explain the underlying risks.
Hauck Aufhäuser Fund Services S.A., one of the principal defendants, rejects those allegations, stating that investors were comprehensively informed through the prospectus and contractual documentation about the nature of the investment, its associated risks and their own responsibility to undertake independent due diligence. Whether that defence succeeds is now a matter for the courts.
REFIRE readers may recognise Hauck Aufhäuser Fund Services as the Luxembourg fund management entity involved in several Deutsche Finance target funds we cover elsewhere in this issue. Those vehicles were, for a period, without a designated management company after Hauck Aufhäuser Fund Services decided to step back, while BaFin, independently, appointed a special representative to review Deutsche Finance’s management of closed‑ended public funds.
The two matters are legally unrelated. Even so, the appearance of the same fund management entity in two separate controversies affecting Germany's alternative property fund market underlines the increasingly important role played by specialist service providers within complex investment structures. As institutional investors continue reassessing counterparty risk across the sector, that coincidence is unlikely to pass unnoticed.
The litigation also extends beyond the financial institutions themselves. The KV Westfalen-Lippe has already dismissed the board member responsible for its Verius investments and is pursuing damages against him before Dortmund Regional Court, alleging breaches of its internal investment guidelines. Accountability, in other words, is no longer confined to fund managers, distributors and advisers but is increasingly reaching those responsible for approving complex investment decisions within public institutions.
Beyond Verius
The Verius litigation also echoes questions raised by Germany's open-ended property fund sector. Although the underlying assets are different, both cases have focused attention on whether increasingly complex investment structures can obscure the risks ultimately being taken by conservative investors.
The questions raised by the litigation are already extending beyond the courtroom. Green Party MP Paula Piechotta has argued that the affair undermines confidence in the ability of health insurance funds to manage public money, while politicians from several parties have called for a comprehensive investigation into how investments of this nature were approved in the first place.
Frankfurt Regional Court is due to hear the first cases in December 2026. Its judgments will determine where the legal boundary lies between investor responsibility and distributor liability.
Whatever the outcome, however, the litigation is already prompting wider questions. How did products ultimately dependent upon mezzanine development finance come to be regarded as suitable investments for institutions whose primary duty was to preserve capital? As Germany's property market continues adjusting to the post-2022 interest-rate shock, that question is likely to resonate well beyond the parties appearing before the court.